LENZ Therapeutics, Inc. (LENZ) Balance Sheet
As of 2026-06-30 (10-Q), LENZ Therapeutics, Inc. (LENZ) reported total assets of $236.6M, total liabilities of $17.3M and shareholders' equity of $219.3M, according to EquiReason's reading of its SEC filings. Cash and equivalents: $24.2M.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
LENZLENZ Therapeutics, Inc.Follow LENZ — free
—
Price chart with a free account
- Market cap
- 99.3M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 29 Oct, in 5 days
| Line | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | Latest Jun 26 | Trend |
|---|---|---|---|---|---|---|---|
| Cash and equivalents | 377.0 | 47.7 | 35.1 | 20.2 | 25.2 | 24.2 | |
| Short-term investments | 0.0 | 220.5 | 30.7 | — | — | — | |
| Receivables | — | — | — | 0.0 | 0.3 | 0.4 | |
| Inventory | — | — | — | 0.0 | 2.9 | 4.1 | |
| Current assets | 381.7 | 275.4 | 67.2 | 211.9 | 301.4 | 233.3 | |
| Total assets | 402.0 | 321.9 | 70.4 | 215.3 | 305.9 | 236.6 | |
| Current liabilities | 12.1 | 13.0 | 18.5 | 10.4 | 21.2 | 17.2 | |
| Total liabilities | 17.9 | 25.6 | 19.7 | 11.2 | 21.5 | 17.3 | |
| Shareholders' equity | 384.1 | -24.2 | -92.7 | 204.1 | 284.3 | 219.3 |
USD millions · SEC XBRL
LENZ Therapeutics, Inc. — questions
- How much cash does LENZ Therapeutics, Inc. have?
- $24.2M in cash and cash equivalents as of 2026-06-30.
- What are LENZ Therapeutics, Inc.'s total assets?
- $236.6M as of 2026-06-30.
- What is LENZ Therapeutics, Inc.'s shareholders' equity?
- $219.3M as of 2026-06-30.
Every figure on this page comes from LENZ Therapeutics, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.